Introduction to the special issue on current trends in laboratory diagnosis and public health of mycobacterial diseases in Korea and highlights in this issue
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Tuberculosis (TB) and other mycobacterial diseases are major public health concerns. Globally,Mycobacterium tuberculosis (MTB) causes > 10 million new TB cases and ~1.5 million deaths eachyear; the incidence of TB has declined by 8.7% from 2015 to 2022, yet the burden remains high [1]. InKorea, incidence of TB has fallen steadily, on average by 7.2% annually since 2011, reflecting sustainedcontrol efforts [2]. In addition to active TB, latent TB infection—along with its intermediate stages, such asincipient and subclinical TB—forms a critical reservoir that fuels future diseases, underscoring the need fortargeted screening and prevention [3]. Meanwhile, nontuberculous mycobacterial (NTM) disease is gainingprominence, with global incidence rising by approximately 4% annually [4] and a growing number of casesreported in Korea since the first pulmonary NTM infections were identified in 1981 [5].
Abstract
Tuberculosis (TB) and other mycobacterial diseases are major public health concerns. Globally,Mycobacterium tuberculosis (MTB) causes > 10 million new TB cases and ~1.5 million deaths eachyear; the incidence of TB has declined by 8.7% from 2015 to 2022, yet the burden remains high [1]. InKorea, incidence of TB has fallen steadily, on average by 7.2% annually since 2011, reflecting sustainedcontrol efforts [2]. In addition to active TB, latent TB infection—along with its intermediate stages, such asincipient and subclinical TB—forms a critical reservoir that fuels future diseases, underscoring the need fortargeted screening and prevention [3]. Meanwhile, nontuberculous mycobacterial (NTM) disease is gainingprominence, with global incidence rising by approximately 4% annually [4] and a growing number of casesreported in Korea since the first pulmonary NTM infections were identified in 1981 [5].